Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.

about

PET Radiometals for Antibody Labeling.

P2860

Q48228929-07B55087-7CE9-452F-B207-DDCDAF104838

P2860

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.

Item

http://www.wikidata.org/entity/Q50499472

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical evaluation of the rad ...... man PET/CT with 152Tb-DOTATOC.

@en

Clinical evaluation of the rad ...... man PET/CT with 152Tb-DOTATOC.

@nl

type

Item

label

Clinical evaluation of the rad ...... man PET/CT with 152Tb-DOTATOC.

@en

Clinical evaluation of the rad ...... man PET/CT with 152Tb-DOTATOC.

@nl

prefLabel

Clinical evaluation of the rad ...... man PET/CT with 152Tb-DOTATOC.

@en

Clinical evaluation of the rad ...... man PET/CT with 152Tb-DOTATOC.

@nl

P1476

Clinical evaluation of the rad ...... uman PET/CT with 152Tb-DOTATOC

@en

P2093

Andreas Türler

http://www.w3.org/2001/XMLSchema#string

Aviral Singh

http://www.w3.org/2001/XMLSchema#string

Dirk Müller

http://www.w3.org/2001/XMLSchema#string

Karl Johnston

http://www.w3.org/2001/XMLSchema#string

Martina Benešová

http://www.w3.org/2001/XMLSchema#string

Stefan Senftleben

http://www.w3.org/2001/XMLSchema#string

P2860

Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Production and in vivo imaging of (203)Pb as a surrogate isotope for in vivo (212)Pb internal absorbed dose studies.

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.

Application of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.

Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate.

Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging

Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease.

Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.

The production, separation, and use of 67Cu for radioimmunotherapy: a review.

Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice.

P304

14638-14646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C7DT01936J

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roger Schibli

John O. Prior

Nicholas P van der Meulen

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28825750

http://www.w3.org/2001/XMLSchema#string

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.

about

P2860

P2860

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698